Bliss GVS Pharma Limited — Board/Management Information 2021

Jul 31, 2021

BLISS GVS PHARMA LTD.

To The General Manager, Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400 001 Scrip Code: 506197 To The Manager, Listing Department National Stock Exchange of India Ltd. Plot no. C/1 G Block, Bandra-Kurla Complex, Bandra (East), Mumbai- 400 051 Symbol: BLISSGVS

Subject: Outcome of Board Meeting held on Saturday, July 31, 2021

Dear Sir/Madam,

0'4\$

~

We would like to inform you that, Board Meeting of the Company was held today i.e. Saturday, July 31, 2021 at the registered office of the Company, In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the following matters amongst others:

• 1. The Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith as' Annexure - I'.
• 1. Re-appointm.ent of Mrs. Shruti Vishal Rao (DIN: 00731501) as Whole-Time Director of the Company for another period of three years with effect from April 01, 2022 to March 31, 2025. The brief profile is enclosed herewith as' Annexure - II'. Further, we would like to state that, as per requirement of Circular No. LIST/COMP/14/2018-19 dated June 20, 2018 w.r.t Enforcement of SEBI order regarding Appointment of Directors by Listed Companies, the Board of Directors and Nomination and Remuneration Committee while considering the appointment of Mrs. Shruti Vishal Rao as Whole-Time Director of the Company have verified and confirmed from her that she is not debarred from holding the office as a Director pursuant to any SEBI order or any other such authority. Accordingly, we hereby affirm that Mrs. Shruti Vishal Rao being appointed as Whole-Time Director is not debarred from holding the office of Director by virtue of any SEBI order or any other such Authority.
• 1. Re-appointment of Dr. Vibha Gagan Shanna (DIN: 02307289) as Whole-Time Director of the Company for another period of three year with effect from January 27, 2022 to January 26, 2025. The brief profile is enclosed herewith as' Annexure - II'. Further, we would like to state that, as per requirement of Circuiar No. LIST/COMP/14/2018-19 dated June 20, 2018 w.r.t Enforcement of SEBI order regarding Appointment of Directors by Listed Companies, the Board of Directors and Nomination and Remuneration Committee while considering the appointment of Dr. Vibha Gagan Sharma as Whole-Time Director of the Company have verified and confirmed from her that she is not debarred from holding the office as a Director P~~ ursuant to any SEBI order or any other such authority. Accordingly, we hereby affirm that Cl} 'r r. Vibha Gagan Sharma being appointed as Whole-Tirne Director is not debarred from ~MUMBAI"-/· olding the office of Director by virtue of any SEBI order or any other such Authority.

: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL .. : (_+91) (2~) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: info@blissgvs.com ·Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. • Email : factory@blissgvs.com Factory:

July 31, 2021

BLISS GVS PHARMA LTD.

• 1. Pursuant to Section 188 of the Companies Act, 2013 and based on the recommendation of the Nomination and Remuneration Committee, Audit Corrunittee and subject to approval of the shareholders of the Company, the Board extended the employment contract of Mr. Vishal Vijay Rao for holding office or place of profit as an employee of the Company in the managerial capacity.
• 1. Re-appointment of M/ s. A VS & Associates, Practicing Company Secretaries as Secretarial Auditor of the Company for the financial year 2021-2022. The brief profile of the Secretarial auditor is enclosed herewith as 'Annexure - III'.
• 1. The Board has constituted the Risk Management Committee pursuant to SEBI (Listing Obligation and Disclosure Requirements) (Second Amendment) Regulations, 2015:
• Constitution of Risk Managem.ent Corrunittee is as follow:

Sr.No.	Name of Members	Desiznation	Position
1	Mrs. Shilpa Bhatia	Independent Director	Chairman
2	Mr. Gagan Harsh Sharma	Managing Director	Member
3	Mr. Vipul B. Thakkar	Chief Financial Officer	Member

• 1. The Board has adopted "Dividend Distribution Policy of Bliss GVS Pharma Limited" pursuant to SEBI (Listing Obligation and Disclosure Requirements) (Second Amendment) Regulations, 2015.
• 1. 36th Annual General Meeting ("AGM") of the Company for the F.Y. 2020-21 has been scheduled to be held on Tuesday, September 21, 2021 through Video Conferencing ("VC")/ Other Audio Visual Means ("OV AM") facility pursuant to MCA General Circular nos. 14/2020, 17 /2020, 20/2020, 02/2021 issued by the Ministry of Corporate Affairs (MCA) and Circular no. SEBI/HO/CFD/CMDl/CIR/P/2020/79 and SEBI/HO/CFD/CMD2/ CIR/P/ 2021/11 issued by the SEBI (hereinafter collectively referred to as "the Circulars") which does not require physical presence of members at common venue.

The meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 17:30 p.m.

Kindly take the above information on your record and acknowledge

Thanking you.

Yours Faithfully,

Encl: As above ~

Factory: Regd. Office: 102, Hyde Pak, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL. : (+91) ( 2) 42160000/ 28505387 • FAX. : (+91) (22) 28563930, Email: info@blissgvs.com ·Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. • Email : factory@blissgvs.com

Annexure - II

Brief Profile of Mrs. Shruti Vishal Rao

Particulars	Details of Appointment
Name of Director	Mrs. Shruti Vishal Rao (DIN: 00731501)
Brief Profile	Mrs. Shruti Vishal Rao, aged 36 years, having total 15 years
	and more experience with Pharma Industry. She holds a
	bachelor's degree in Engineering from Mumbai University.
	She is currently designated as Whole-Time Director of the
	She is a part of promoter Company. group exclusively
	working for the company and oversees the day to day
	commercial and trading activities of the Company in India
	& abroad.
appointment & Date of	Re-Appointment of Mrs. Shruti Vishal Rao (DIN: 00731501)
Term of appointment	as a Whole-Time Director of the Company for a period of
	Three years with effect from April 01, 2022 to March 31,
	2025.
Disclosure of relationships	Mrs. Shruti Vishal Rao is related to Promoter & Director of
between directors	the Company in the following manner:
	Daughter Karnath, Promoter of the of Mr. S. N. 1.
	Company
	Sister of Dr. Vibha Gagan Sharma, Whole Time 2.
	Director of the Company.
	Sister-in-Law Sharma, Mr. Harsh of Gagan 3.
	Managing Director of the Company.

Brief Profile of Dr. Vibha Gagan Sharma

Particulars	Details of Appointment
Name of Director	Dr. Vibha Gagan Sharma (DIN: 02307289)
Brief Profile	Dr. Vibha Gagan Shanna, aged 38 years, having total 13
	with Pharma Industry. She years and more experience
	holds a bachelor's degree in Dental Surgery from Rajiv
	Gandhi University of Health Sciences, Kamataka. She is
	currently designated Director Whole-Time as of the
	group exclusively Company. She is a part of promoter
	working for the company and oversees the research &
	development activities of the Company.
Date of appointment & Term	Appointment of Dr. Vibha Gagan Sharma (DIN: 02307289)
of appointment	as a Whole-Time Director of the Company for a period of
	Three years with effect from January 27, 2022 to January 26,
	2025.
of relationships Disclosure	Dr. Vibha Gagan Sharma is related to Promoter & Director
between directors	of the Company in the following manner:
	Karnath, Promoter Daughter of Mr. of the S. N. 1.
	Company
	Sharma, Managing Harsh Wife of Mr. Gagan 2.
	Director of the Company.
	Sister of Mrs. Shruti Vishal Rao, Whole Time 3.
	Director of the Company.